Welcome to the ValueWiki SOLAGRAN LIMITED (SLA.AX) article! Register for free or click the "edit" link to contribute!
SOLAGRAN LIMITED (SLA.AX)
From ValueWiki
Business Description from asx.com.au: Research and development of bio-medical products used in the treatment of cirrhosis, chronic hepatitis and other liver conditions.[1]
You can add information to this page! Just click any blue [ edit ] link to contribute.
|
|
[edit]
Company Analysis
You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.
The edit window has shortcut and help links if you need them.[2] Be bold!
[edit]
News Feed
[edit]
Leadership
- SOLAGRAN LIMITED Executive Information
- SOLAGRAN LIMITED Directors / Senior Management[1]
Dr Vagif Soultanov (Chairman, Director) Mr Peter Stedwell (Executive Director) Mr Denis Kilroy (Executive Director) Mr Charles Pellegrino (Director)
[edit]
Risks
This section needs content! Click the blue edit link (to the right) to contribute.
[edit]
Research Links
- SOLAGRAN LIMITED Profile
- SOLAGRAN LIMITED Fundamentals
- SOLAGRAN LIMITED Technical Analysis
- SOLAGRAN LIMITED Contact Information[1]
- Website: http://www.solagran.com
- Address: Level 11 , 492 St Kilda Road , MELBOURNE , VIC, AUSTRALIA, 3004
- Phone: (03) 9820 2699
- Fax: (03) 9820 3155
- Share Registry: COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 2, RESERVE BANK BUILDING , 45 ST GEORGE'S TERRACE , PERTH , WA, AUSTRALIA, 6000
- Share Registry Phone: 1300 787 575 (BKR ONLY)
- SOLAGRAN LIMITED Message Boards
[edit]
Notes
- ↑ 1.0 1.1 1.2 http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=SLA ASX.com.au
- ↑ This is a sample reference.
